Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Net Income ScalingExpanding
Percentile Rank67
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-38.63M
↑ 43% vs avg
Percentile
P67
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-67.58M
Historical baseline
PeriodValueYoY Change
TTM$-38.63M+46.9%
2024$-72.70M+46.3%
2023$-135.35M-24.7%
2022$-108.50M-46.7%
2021$-73.96M-106.1%
2020$-35.88M-347.5%
2019$-8.02M-